Is MEK Inhbitor Therapy the Best Treatment Recommendation for Low-Grade Serous Ovarian Cancer Patients at First Relapse? Uncommon Gynecologic Cancers. In: Cancer Consult: Expertise for Clinical Practice Volume 1—Solid Tumors
